{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T21:41:22Z","timestamp":1773956482443,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.ijcard.2023.02.021","type":"journal-article","created":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T16:03:31Z","timestamp":1676390611000},"page":"55-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Prognostic impact of cardiovascular polypharmacy on octogenarians with heart failure with preserved ejection fraction"],"prefix":"10.1016","volume":"378","author":[{"given":"Masami","family":"Nishino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyuki","family":"Egami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shodai","family":"Kawanami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Sugae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Ukita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akito","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Yasumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Tsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naotaka","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuharu","family":"Matsunaga-Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masamichi","family":"Yano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Tanouchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahisa","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Yasumura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Seo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Tamaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaharu","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akito","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohei","family":"Sotomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisaku","family":"Nakatani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shungo","family":"Hikoso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Sakata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2023.02.021_bb0005","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s11897-014-0186-8","article-title":"Polypharmacy in heart failure patients","volume":"11","author":"Mastromarino","year":"2014","journal-title":"Curr. Heart. Fail. Rep."},{"key":"10.1016\/j.ijcard.2023.02.021_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2016.02.007","article-title":"Characteristics of hospitalizations for heart failure with preserved ejection fraction","volume":"129","author":"Goyal","year":"2016","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ijcard.2023.02.021_bb0015","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","article-title":"Spironolactone for heart failure with preserved ejection fraction","volume":"370","author":"Pitt","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2023.02.021_bb0020","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2023.02.021_bb0025","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1038\/s41591-021-01536-x","article-title":"The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial","volume":"27","author":"Nassif","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijcard.2023.02.021_bb0030","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1517\/14740338.2013.827660","article-title":"Clinical consequences of polypharmacy in elderly","volume":"13","author":"Maher","year":"2014","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.ijcard.2023.02.021_bb0035","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/pds.1984","article-title":"Adverse drug events in the outpatient setting: an 11-year national analysis","volume":"19","author":"Bourgeois","year":"2010","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.ijcard.2023.02.021_bb0040","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1161\/01.CIR.101.17.2118","article-title":"Defining diastolic heart failure: a call for standardized diagnostic criteria","volume":"101","author":"Vasan","year":"2000","journal-title":"Circulation."},{"key":"10.1016\/j.ijcard.2023.02.021_bb0045","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12877-017-0621-2","article-title":"What is polypharmacy? A systematic review of definitions","volume":"17","author":"Masnoon","year":"2017","journal-title":"BMC Geriatr."},{"key":"10.1016\/j.ijcard.2023.02.021_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"28","author":"Lang","year":"2015","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"10.1016\/j.ijcard.2023.02.021_bb0055","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","volume":"33","author":"McMurray","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2023.02.021_bb0060","doi-asserted-by":"crossref","first-page":"4276047","DOI":"10.1155\/2017\/4276047","article-title":"Diseases linked to polypharmacy in elderly patients","volume":"2017","author":"Vrettos","year":"2017","journal-title":"Curr. Gerontol. Geriatr. Res."},{"key":"10.1016\/j.ijcard.2023.02.021_bb0065","first-page":"214","article-title":"Patterns and determinants of cardiovascular drug utilization in coronary care unit patients of a tertiary care hospital","volume":"4","author":"George","year":"2013","journal-title":"J. Cardiovasc. Dis. Res."},{"key":"10.1016\/j.ijcard.2023.02.021_bb0070","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s00392-015-0936-y","article-title":"Polypharmacy and major adverse events in atrial fibrillation: observations from the AFFIRM trial","volume":"105","author":"Proietti","year":"2016","journal-title":"Clin. Res. Cardiol."},{"key":"10.1016\/j.ijcard.2023.02.021_bb0075","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1111\/echo.13306","article-title":"Left atrial changes in early stages of heart failure with preserved ejection fraction","volume":"33","author":"Byty\u00e7i","year":"2016","journal-title":"Echocardiography."},{"key":"10.1016\/j.ijcard.2023.02.021_bb0080","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/hr.2016.29","article-title":"Left atrial dimension is related to blood pressure variability in newly diagnosed untreated hypertensive patients","volume":"39","author":"Cipollini","year":"2016","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.ijcard.2023.02.021_bb0085","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/bcp.13590","article-title":"The relationship between frailty and polypharmacy in older people: a systematic review","volume":"84","author":"Guti\u00e9rrez-Valencia","year":"2018","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ijcard.2023.02.021_bb0090","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1111\/jgs.16212","article-title":"Polypharmacy and incident frailty in a longitudinal community-based cohort study","volume":"67","author":"Shmuel","year":"2019","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.ijcard.2023.02.021_bb0095","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1136\/bmj.39503.424653.80","article-title":"Prescribing for older people","volume":"336","author":"Milton","year":"2008","journal-title":"BMJ."},{"key":"10.1016\/j.ijcard.2023.02.021_bb0100","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/ggi.13796","article-title":"Clinical medication review typeIII of polypharmacy reduced unplanned hospitalizations in older adults: a meta-analysis of randomized clinical trials","volume":"19","author":"Mizokami","year":"2019","journal-title":"Geriatr Gerontol Int"},{"key":"10.1016\/j.ijcard.2023.02.021_bb0105","doi-asserted-by":"crossref","first-page":"679","DOI":"10.2147\/CIA.S130832","article-title":"Medication regimen complexity in ambulatory older adults with heart failure","volume":"12","author":"Cobretti","year":"2017","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.ijcard.2023.02.021_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206120","article-title":"Drug therapy problems and contributing factors in the management of heart failure patients in Jimma University Specialized Hospital, Southwest Ethiopia","volume":"13","author":"Niriayo","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2023.02.021_bb0115","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ejheart.2003.09.009","article-title":"Pharmacological treatment in patients with heart failure: patients knowledge and occurrence of polypharmacy, alternative medicine and immunizations","volume":"6","author":"Mart\u00ednez-Sell\u00e9s","year":"2004","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2023.02.021_bb0120","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s10741-021-10135-4","article-title":"Polypharmacy definition and prevalence in heart failure: a systematic review","volume":"27","author":"Beezer","year":"2022","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.ijcard.2023.02.021_bb0125","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jacc.2016.10.078","article-title":"Mode of death in heart failure with preserved ejection fraction","volume":"69","author":"Vaduganathan","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2023.02.021_bb0130","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1093\/eurjhf\/hft062","article-title":"How do patients with heart failure with preserved ejection fraction die?","volume":"15","author":"Chan","year":"2013","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2023.02.021_bb0135","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.3399\/bjgp21X714245","article-title":"Influence of polypharmacy on patients with heart failure with preserved ejection fraction: a retrospective analysis on adverse outcomes in the TOPCAT trial","volume":"71","author":"Wu","year":"2021","journal-title":"Br. J. Gen. Pract."},{"key":"10.1016\/j.ijcard.2023.02.021_bb0140","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1002\/ehf2.13293","article-title":"Impact of readmissions on octogenarians with heart failure with preserved ejection fraction: PURSUIT-HFpEF registry","volume":"8","author":"Nishino","year":"2021","journal-title":"ESC Heart Fail."},{"key":"10.1016\/j.ijcard.2023.02.021_bb0145","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.cardfail.2014.03.006","article-title":"Insufficient natriuretic response to continuous intravenous furosemide is associated with poor long-term outcomes in acute decompensated heart failure","volume":"20","author":"Singh","year":"2014","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.ijcard.2023.02.021_bb0150","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1253\/circj.CJ-16-0216","article-title":"Prognostic impact of loop diuretics in patients with chronic heart failure - effects of addition of renin-angiotensin-aldosterone system inhibitors and \u03b2-blockers","volume":"80","author":"Miura","year":"2016","journal-title":"Circ. J."},{"issue":"2016","key":"10.1016\/j.ijcard.2023.02.021_bb0155","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2023.02.021_bb0160","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1177\/1060028015621071","article-title":"Medication regimen complexity and polypharmacy as factors associated with all-cause mortality in older people: a population-based cohort study","volume":"50","author":"Wimmer","year":"2016","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.ijcard.2023.02.021_bb0165","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1186\/s12877-018-0978-x","article-title":"The deprescribing rainbow: a conceptual framework highlighting the importance of patient context when stopping medication in older people","volume":"18","author":"Todd","year":"2018","journal-title":"BMC Geriatr."},{"key":"10.1016\/j.ijcard.2023.02.021_bb0170","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1161\/CIRCHEARTFAILURE.113.001281","article-title":"Influence of previous heart failure hospitalization on cardiovascular events in patients with reduced and preserved ejection fraction","volume":"7","author":"Bello","year":"2014","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.ijcard.2023.02.021_bb0175","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/eurheartj\/ehs444","article-title":"Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial","volume":"34","author":"Ambrosy","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2023.02.021_bb0180","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.006977","article-title":"Polypharmacy in older adults hospitalized for heart failure","volume":"13","author":"Unlu","year":"2020","journal-title":"Circ. Heart Fail."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527323002371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527323002371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T21:00:04Z","timestamp":1759093204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527323002371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":36,"alternative-id":["S0167527323002371"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2023.02.021","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic impact of cardiovascular polypharmacy on octogenarians with heart failure with preserved ejection fraction","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2023.02.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}